AbbVie : ABBV

All AbbVie Articles

622 Articles

Jon C. Ogg | Jan 3, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First…

Chris Lange | Dec 27, 2018 at 10:00 AM EST

Short Sellers Hike Bets in Major Pharma Stocks

The December 14 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 12, 2018 at 9:50 AM EST

Major Pharma Stocks See a Surge in Short Interest

The November 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 28, 2018 at 9:00 AM EST

Short Sellers Hike Their Bets in Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 12, 2018 at 10:10 AM EST

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 6, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included AbbVie, AMAG Pharmaceuticals, Crocs, HCA, Kellogg, Kosmos Energy, Mylan,…

Chris Lange | Nov 2, 2018 at 10:23 AM EDT

AbbVie Little Changed Despite Big Bottom-Line Beat

AbbVie released its third quarter financial results before the markets opened on Friday. The pharma giant said that it had…

Paul Ausick | Nov 1, 2018 at 2:08 PM EDT

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

Encana, Hanesbrands, Abbvie, and Annaly Capital Management all posted new 52-week lows Thursday.

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Oct 25, 2018 at 7:10 AM EDT

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Oct 4, 2018 at 12:10 PM EDT

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

Here are 13 companies with solid dividends that currently yield more than both the 10-year Treasury note and the 30-year…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 19, 2018 at 1:50 PM EDT

Should AbbVie Be More Concerned About Its California Case for Humira?

AbbVie shares took a dip on Wednesday after it was announced that the pharma giant would be facing a lawsuit…

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 20 21 22 23 24 … 42

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

AbbVie Little Changed Despite Big Bottom-Line Beat

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Short Sellers Run for Cover From Major Pharma

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

Short Sellers Grow More Selective on Major Pharma Stocks

Should AbbVie Be More Concerned About Its California Case for Humira?

Short Sellers Back Off Major Pharma Stocks

How Much Do You Need Invested at 60 to Bridge the Gap Until Social Security at 70?

A $2,400 Water Heater Nearly Pushed Him Into Social Security at 62. His 401(k) Held an Escape Hatch.

‘I Don’t Think She’s Entitled to a Freaking Dime’: Dave Ramsey to Mom Debating Whether to Cut Estranged Daughter From Her Will

How Much Do You Need Invested at 60 to Bridge the Gap Until Social Security at 70?

A $2,400 Water Heater Nearly Pushed Him Into Social Security at 62. His 401(k) Held an Escape Hatch.

Amazon’s New Texas Data Center On Track To Be Biggest Polluter In America

Elon Musk Plans to Spend $119 Billion to Construct the World’s Largest Building, Just Outside Houston

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

AbbVie Little Changed Despite Big Bottom-Line Beat

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Short Sellers Run for Cover From Major Pharma

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

Short Sellers Grow More Selective on Major Pharma Stocks

Should AbbVie Be More Concerned About Its California Case for Humira?

Short Sellers Back Off Major Pharma Stocks

How Much Do You Need Invested at 60 to Bridge the Gap Until Social Security at 70?

A $2,400 Water Heater Nearly Pushed Him Into Social Security at 62. His 401(k) Held an Escape Hatch.

‘I Don’t Think She’s Entitled to a Freaking Dime’: Dave Ramsey to Mom Debating Whether to Cut Estranged Daughter From Her Will

Featured Reads

How Much Do You Need Invested at 60 to Bridge the Gap Until Social Security at 70?

A $2,400 Water Heater Nearly Pushed Him Into Social Security at 62. His 401(k) Held an Escape Hatch.